Methotrexate (for the treatment of certain conditions)

Methotrexate is a medicine used for a range of immune-mediated diseases and, in some cases, certain types of cancer. In the UK, it is widely prescribed under specialist supervision and is available in different strengths and formulations, including tablets and injections.

This guide is designed to help you understand what methotrexate does, how it works, what to expect, how to take it safely, and when to seek medical advice. If anything in this information conflicts with advice from your healthcare professional, follow the professional guidance.

Basic product information

• Generic name: Methotrexate
• Common brand examples (may vary by supplier): Various brands and generics are available in the UK
• Formulations: Tablets, and sometimes injections (depending on condition and local availability)
• How it is taken: Usually once weekly for inflammatory/autoimmune conditions (not daily)
• Typical “strength”: Strengths vary by product (your pack will specify mg per tablet)
• Classification: Antimetabolite / immunosuppressant (also used in cancer therapy)

Important: Methotrexate for inflammatory conditions is taken on a weekly schedule. Taking it more often than directed increases the risk of serious side effects.

How methotrexate works (mechanism of action)

Methotrexate belongs to a group of medicines called antimetabolites. It affects how rapidly cells use folate (a vitamin needed for DNA synthesis and cell replication).

At the doses used for many autoimmune and inflammatory conditions, methotrexate mainly works by reducing abnormal immune activity. It helps lower inflammation and can slow disease progression, particularly in conditions such as rheumatoid arthritis and certain types of skin disease.

In brief, methotrexate:

• Interferes with folate-dependent cellular processes, which may reduce proliferation of rapidly dividing cells.
• Modulates immune responses, lowering inflammatory signalling.
• Over time, helps reduce symptoms such as pain, swelling, stiffness, and skin plaques (where relevant).

Pharmacokinetics (how the body handles it)

“Pharmacokinetics” describes what the body does with the medicine: absorption, distribution, metabolism, and elimination.

• Absorption: Methotrexate tablets are absorbed from the gut, but absorption can vary between individuals and may be affected by certain factors (including gastrointestinal issues).
• Distribution: It distributes into body tissues. Methotrexate can bind to plasma proteins and may accumulate in some tissues.
• Metabolism: It is metabolised mainly in the liver to related compounds, some of which can remain active for a period.
• Elimination: Methotrexate and its metabolites are cleared primarily by the kidneys. This is why kidney function is important.

Monitoring is key because levels can be affected by kidney and liver function, and because drug accumulation may increase the risk of toxicity.

Typical use in the UK

Methotrexate is commonly used in the UK to treat:

• Rheumatoid arthritis (RA)
• Psoriatic arthritis
• Severe psoriasis (particularly when other treatments are unsuitable)
• Other inflammatory/immune conditions as determined by specialist clinicians
• Certain cancers in hospital settings, under oncology protocols

The choice of dose, formulation, and monitoring schedule depends on the condition being treated, your medical history, kidney/liver function, and other medicines you take.

When and how to take methotrexate (timing and schedule)

The most important practical point for patients is the weekly schedule.

Weekly dosing: the usual approach

• Take methotrexate once a week for many immune-mediated conditions.
• Choose one specific day of the week and try to keep the same day each week.
• Do not take it daily unless your clinician has specifically instructed you for a particular cancer regimen.

If you miss a dose

Because the dosing schedule can differ by indication, do not improvise. Contact your healthcare professional or follow your patient information leaflet for advice on what to do if a weekly dose is missed. If you accidentally take an extra dose, seek urgent medical advice.

How to take tablets

• Follow the instructions on your pack.
• Take with water.
• If prescribed, use folic acid or folate supplements (often recommended to reduce side effects).
• If you feel nauseated, your clinician may advise taking it at a time of day that suits you or adjusting supportive measures.

Food interactions (what to know about eating)

For most people, food does not completely prevent methotrexate from working, but it can influence how comfortable you feel and, in some cases, how well the medicine is tolerated.

• General advice: Taking methotrexate with food may help reduce stomach upset for some patients.
• Consistency helps: Try to take it in a consistent way each week.
• Folate supplementation: If you take folic acid, keep timing consistent according to your plan (for example, folic acid on the days recommended by your prescriber).

Special situations: If you have stomach irritation, mouth ulcers, or diarrhoea, speak to your healthcare team—your dose may need adjustment and supportive care may be needed.

Alcohol and medicine interactions

Alcohol

Alcohol can increase the risk of liver problems. Because methotrexate can also affect the liver, it is generally recommended that patients:

• Avoid heavy or binge drinking.
• Limit alcohol, often to low or occasional amounts, depending on your overall risk and liver monitoring results.
• Discuss your typical alcohol intake with your healthcare professional, particularly if you have liver disease or abnormal blood tests.

Other medicines that may interact

Methotrexate has interactions with several common medications. The most relevant include:

• Other folate antagonists (or medicines affecting folate metabolism)
• Non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen, diclofenac, naproxen) — can increase methotrexate levels in certain circumstances, especially with dehydration or kidney impairment
• Antibiotics such as trimethoprim/sulfamethoxazole (co-trimoxazole) — can increase risk of blood cell suppression
• Proton pump inhibitors (PPIs) (e.g., omeprazole) — may increase methotrexate exposure in some cases
• Some antivirals and medicines used in infection control — require careful review
• Vaccines: live vaccines may be unsafe for some patients taking immunosuppressive doses

Always tell your pharmacist or healthcare professional about all medicines and supplements you use, including over-the-counter products and herbal remedies.

Indications: what methotrexate is used for

In everyday UK clinical practice, methotrexate is typically used as a long-term disease-modifying treatment for:

• Rheumatoid arthritis (RA): to reduce inflammation, pain, swelling, and prevent joint damage.
• Psoriatic arthritis: to control joint and skin symptoms.
• Severe psoriasis: particularly when disease is widespread, persistent, or unresponsive to topical therapy or other systemic options.

For oncology indications, dosing schedules and monitoring can be different and are managed within specialised settings.

Dosing: typical schedules and general principles

Dose varies widely by condition, age, kidney/liver function, and treatment goals. For safety, always follow your specific pack instructions and clinician advice.

General principles for dosing in inflammatory conditions

• Weekly dosing is standard (for RA, psoriatic arthritis, and many cases of psoriasis).
• Doses are often started at a lower level and gradually adjusted (“titrated”) based on response and blood test results.
• Folic acid supplementation is commonly prescribed alongside methotrexate to reduce side effects.

Adjustments and monitoring

Your dose may be adjusted if you have:

• Abnormal blood results (e.g., low white blood cells, anaemia, or low platelets)
• Kidney impairment (reduced clearance)
• Liver function changes
• Significant side effects such as mouth ulcers, persistent vomiting, or severe diarrhoea

Do not change your dose or stop/start methotrexate without medical advice.

Safety profile: what to watch for

Like all medicines, methotrexate can cause side effects. Many people tolerate it well with regular monitoring and supportive measures, but it requires caution because it can affect the blood, liver, and lungs.

Common or expected side effects

• Stomach upset, nausea, reduced appetite
• Fatigue
• Mouth ulcers or irritation in the mouth
• Hair thinning in some cases
• Headache
• Skin sensitivity (rarely)

Serious side effects (seek prompt medical advice)

Contact your healthcare professional urgently or seek urgent care if you develop symptoms suggesting:

• Infection: fever, chills, sore throat, or unusual infections
• Blood problems: unusual bruising, bleeding, marked tiredness, or pallor
• Lung involvement: new or worsening shortness of breath, dry cough, or chest discomfort
• Severe mouth sores or inability to eat/drink
• Liver problems: yellowing of the eyes/skin, dark urine, severe abdominal pain
• Severe diarrhoea or vomiting (which can also affect kidney function)

Blood and liver monitoring

In the UK, patients taking methotrexate commonly undergo periodic blood tests to monitor:

• Full blood count (FBC)
• Liver enzymes
• Renal function (creatinine/eGFR)

The exact frequency depends on your dose, duration of treatment, and any risk factors. If you have symptoms, monitoring may occur sooner.

Fertility, pregnancy, and contraception (general safety)

Methotrexate can be harmful to an unborn baby. For patients of childbearing potential, discuss contraception and family planning with your clinician before starting treatment and throughout therapy. If pregnancy is possible or planned, contact your healthcare professional promptly.

Practical use tips (making treatment easier)

• Use a weekly reminder: Set a phone alarm for your methotrexate day. This helps prevent accidental daily dosing.
• Keep a medication diary: Record dose timing and any side effects.
• Hydration matters: Dehydration can increase risk of toxicity, especially if you are unwell.
• Report new symptoms early: Mouth sores, persistent nausea, or breathing changes should not be ignored.
• Take folic acid as advised: This can reduce certain side effects such as mouth ulcers and blood count changes.
• Prevent interactions: Check with your pharmacist before starting antibiotics, new anti-inflammatory medicines, or supplements.
• Sun protection: Some patients may be more sensitive; using sun protection can help.

Good to know: If you experience vomiting, diarrhoea, or you become significantly unwell, contact your healthcare team promptly. It may be necessary to pause treatment temporarily while you recover, but only under professional advice.

Alternative options (if methotrexate is not suitable)

Depending on the condition being treated and your personal circumstances, clinicians may consider other therapies. Options can include:

For rheumatoid arthritis and psoriatic arthritis

• Other conventional DMARDs (disease-modifying anti-rheumatic drugs), such as sulfasalazine or leflunomide
• Biologic therapies (targeted medicines)
• Targeted synthetic DMARDs (oral agents that target specific inflammatory pathways)
• Adjunct treatments for symptom control (e.g., short-term anti-inflammatory strategies)

For psoriasis

• Topical therapies (for mild to moderate disease)
• Phototherapy
• Other systemic treatments (including biologics and targeted therapies depending on severity)

Your healthcare professional will select alternatives based on disease severity, risk factors (such as liver/kidney function), previous treatment history, and preference.

Market and legal context in the United Kingdom

In the UK, methotrexate is an established medicine with structured safety requirements and monitoring protocols used by healthcare providers. The UK medicines landscape includes:

• Regulatory oversight: Medicines are regulated by the UK’s medicines regulatory authorities and supplied under controlled governance.
• Specialist use in many cases: It is typically prescribed and monitored by clinicians familiar with immune-mediated disease management.
• Patient safety measures: Because methotrexate dosing errors can occur, healthcare systems emphasise clear labelling and patient education about the weekly schedule.
• Ongoing safety communications: The UK health system issues updates and guidance when new safety information emerges.

For the most current advice in your situation, always refer to official patient information leaflets and guidance from your healthcare professional.

Recent guidance (what to expect in practice)

While recommendations can evolve, current practice in the UK generally focuses on:

• Regular blood monitoring for blood counts, liver enzymes, and kidney function.
• Clear dosing instructions to reinforce weekly intake (for inflammatory conditions).
• Folate supplementation as commonly recommended to reduce side effects.
• Review of interacting medicines, particularly antibiotics and anti-inflammatory agents.
• Risk-based monitoring for patients with liver disease, kidney impairment, or additional risk factors.

If you have questions about whether your monitoring schedule matches your treatment plan, speak to your GP, specialist nurse, or rheumatology/dermatology team.

Delivery and availability in the UK

Availability of methotrexate may depend on local supply chains and the specific strength/formulation you need. For online purchasing, availability can vary by product presentation (tablets versus injection-ready options).

• Dispatch times: Many pharmacies dispatch quickly when stock is available; dispatch may be delayed if the item is temporarily out of stock.
• Packaging: Your medicine should arrive in secure, tamper-evident packaging with clear labelling.
• Delivery method: Commonly standard or tracked delivery (depending on the service level selected).
• Cold chain: Methotrexate tablets typically do not require refrigeration, but some formulations may have specific storage requirements—check your product’s leaflet.

For the best experience, confirm the product strength, formulation, and dosage instructions before placing an order. If you are unsure which option is right for you, speak with a pharmacist.

FAQ: Frequently asked questions

1) Why is methotrexate taken once a week?

For many inflammatory conditions treated in the UK (such as rheumatoid arthritis, psoriatic arthritis, and severe psoriasis), methotrexate is scheduled once weekly to balance benefits and safety. Taking it more frequently than advised increases risk of serious side effects.

2) How long does methotrexate take to work?

Some people notice improvements within a few weeks, but full benefit can take several months. Treatment response varies. Your clinician may adjust the dose based on symptoms and blood monitoring results.

3) Do I need folic acid?

Many patients are prescribed folic acid alongside methotrexate to reduce side effects (often including mouth ulcers and some blood count changes). Always use folic acid exactly as advised for your weekly schedule.

4) Can I drink alcohol while taking methotrexate?

Alcohol may increase the risk of liver side effects. Most guidance recommends limiting alcohol, and avoiding heavy drinking. Your healthcare team may recommend an even stricter limit based on your liver blood tests and personal risk factors.

5) What should I do if I accidentally take an extra dose?

Do not wait for symptoms. Contact urgent medical advice or your healthcare team immediately, especially if you have taken more than the prescribed weekly amount. Errors are considered a medical safety issue.

6) Are there foods I should avoid?

There are no strict universal food prohibitions for methotrexate tablets. However, taking it with food may reduce stomach upset for some people. If you notice specific foods worsen nausea, adjust your routine and discuss with your clinician.

7) Can I take ibuprofen or other painkillers?

Some anti-inflammatory medicines can interact with methotrexate, particularly in situations such as kidney impairment or dehydration. It’s best to check with your pharmacist or clinician before regular use of NSAIDs.

8) Will I be monitored with blood tests?

Regular monitoring is commonly used in the UK to check blood counts, liver enzymes, and kidney function. The frequency is determined by your dose, condition, and risk factors.

9) Can I get vaccines?

Some vaccines may be unsuitable for people on immunosuppressive therapy, especially live vaccines. Inactivated vaccines may still be recommended. Ask your healthcare team for advice.

10) What if I feel unwell after taking methotrexate?

If you develop significant nausea, vomiting, diarrhoea, fever, infection symptoms, breathing problems, mouth ulcers, or signs of liver problems, contact your healthcare professional promptly. Severe illness may require treatment adjustment and urgent assessment.

Summary

Methotrexate is a long-standing medicine used in the UK for immune-mediated conditions such as rheumatoid arthritis, psoriatic arthritis, and severe psoriasis, and it is also used in cancer therapy under specialist protocols. It works by modulating immune activity and affecting folate-dependent processes. Because it can impact the blood, liver, and lungs—and because it is mainly cleared by the kidneys—safe use depends on correct weekly dosing, regular monitoring, and careful management of interactions.

If you have questions about your specific product, dosing day, monitoring schedule, or interactions with other medicines, consult a pharmacist or your healthcare team.